Nakajima T - Search Results

1

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Nomoto T, Iwasaki Y, Otani Y, Tsuchiya S, Saito R, Dobashi K, Nakajima T, Mori M. Tomizawa Y, et al. Among authors: nakajima t. Lung Cancer. 2004 Dec;46(3):305-12. doi: 10.1016/j.lungcan.2004.05.003. Lung Cancer. 2004. PMID: 15541815

2

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.

Iijima H, Tomizawa Y, Iwasaki Y, Sato K, Sunaga N, Dobashi K, Saito R, Nakajima T, Minna JD, Mori M. Iijima H, et al. Among authors: nakajima t. Int J Cancer. 2006 Feb 15;118(4):797-801. doi: 10.1002/ijc.21462. Int J Cancer. 2006. PMID: 16152584

3

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Sunaga N, Sato K, Takise A, Otani Y, Tanaka S, Suga T, Saito R, Ishizuka T, Dobashi K, Minna JD, Nakajima T, Mori M. Tomizawa Y, et al. Among authors: nakajima t. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6816-22. doi: 10.1158/1078-0432.CCR-05-0441. Clin Cancer Res. 2005. PMID: 16203769

4

Epigenetic inactivation of the RUNX3 gene in lung cancer.

Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M. Sato K, et al. Among authors: nakajima t. Oncol Rep. 2006 Jan;15(1):129-35. Oncol Rep. 2006. PMID: 16328045

5

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.

Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Ishizuka T, Saito R, Nakajima T, Mori M. Kaira K, et al. Among authors: nakajima t. Int J Oncol. 2007 Jul;31(1):169-73. Int J Oncol. 2007. PMID: 17549418

6

The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens.

Ishihara S, Minato K, Hoshino H, Saito R, Hara F, Nakajima T, Mori M. Ishihara S, et al. Among authors: nakajima t. Lung Cancer. 1999 Dec;26(3):187-94. doi: 10.1016/s0169-5002(99)00085-9. Lung Cancer. 1999. PMID: 10598929

7

Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.

Iijima H, Tomizawa Y, Dobashi K, Saito R, Nakajima T, Mori M. Iijima H, et al. Among authors: nakajima t. Br J Cancer. 2004 Sep 13;91(6):1143-8. doi: 10.1038/sj.bjc.6602005. Br J Cancer. 2004. PMID: 15292942 Free PMC article.

8

Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.

Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J. Tomizawa Y, et al. Among authors: nakajima t. Cancer Res. 1998 Dec 1;58(23):5478-83. Cancer Res. 1998. PMID: 9850082

9

Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.

Jian Z, Tomizawa Y, Yanagitani N, Iijima H, Sano T, Nakajima T. Jian Z, et al. Among authors: nakajima t. Pathol Int. 2005 Oct;55(10):619-25. doi: 10.1111/j.1440-1827.2005.01879.x. Pathol Int. 2005. PMID: 16185291

10

Prognostic model of stage II non-small cell lung cancer by a discriminant analysis of the immunohistochemical protein expression.

Kohri T, Sugano M, Kawashima O, Saito R, Sakurai S, Sano T, Nakajima T. Kohri T, et al. Among authors: nakajima t. Surg Today. 2006;36(12):1039-46. doi: 10.1007/s00595-006-3319-1. Epub 2006 Dec 25. Surg Today. 2006. PMID: 17123130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,012 results

Search Page

Filters